Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Miller Thomson LLP
In Broader Public Sector Accountability Bill Re-introduced, we provided an overview of Bill 8, the proposed Public Sector and MPP Accountability and Transparency Act, 2014.
Bull, Housser & Tupper LLP
On October 29, 2014, Madam Justice Adair issued an oral decision interpreting section 46(6) of the Hospital Act for the first time.
Borden Ladner Gervais LLP
On July 8, 2014, the Ontario government re-introduced Bill 8, formerly Bill 179, which proposes to amend several laws affecting health sector organizations
Norton Rose Fulbright Canada LLP
The Nagoya Protocol on Access and Benefit-sharing (the Protocol), adopted in 2010 by the parties to the Convention on Biological Diversity (the Convention), entered into force in October 2014.
Norton Rose Fulbright Canada LLP
The Supreme Court of Canada has refused Teva’s application for leave to appeal the decision of the Federal Court of Appeal.
Norton Rose Fulbright Canada LLP
There have been a number of notable developments in recent weeks in respect of patent utility law in Canada.
Davis LLP
On November 6, 2014, Bill C-17 (the Protecting Canadians from Unsafe Drugs Act, aka Vanessa’s Law) (the "Act") received Royal Assent and came into law.
Miller Thomson LLP
Bill C-17, the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) was passed by the federal legislature and received Royal Assent on November 6, 2014.
Osler, Hoskin & Harcourt LLP
Health Canada has released its long-anticipated findings in the landmark Wind Turbine Noise and Health Study – the largest and most comprehensive study of its kind in the world.
Blake, Cassels & Graydon LLP
Bill C-17, An Act to Amend the Food and Drugs Act, received royal assent on November 6, 2014.
Norton Rose Fulbright Canada LLP
Bill C-17, An Act to Amend the Food and Drugs Act, reported in our earlier Pharma in Brief has now passed through Parliament and was given Royal Assent on November 6, 2014.
MNP
Most people are aware that Canada’s food & beverage processing industry, as well as our agriculture sector, is a major component of our nation’s GDP.
Torys LLP
On October 18, 2014, proposed regulations seeking to amend the Medical Devices Regulations (Regulations) were published in the Canada Gazette.
Norton Rose Fulbright Canada LLP
The report of consultant, IBM Healthcare, contracted to study the system of pan-Canadian price negotiations, has been publicly released.
TTL Health Law
Not unlike the debate currently going on before the Supreme Court of Canada surrounding physician assisted suicide, we have seen and heard public outcry and resistance to changes in laws governing social and moral issues before.
Osler, Hoskin & Harcourt LLP
This article examines the separate, potentially competing, duties of care that are owed by hospital boards of directors to staff and patients during infectious disease outbreaks.
Borden Ladner Gervais LLP
This article aims to give a general outline of the changes that have been announced, several of which might be implemented during the coming year.
Torkin Manes LLP
For years, opticians and optometrists have been advocating for greater flexibility with respect to their relationships with their counterparts on the other side of the glass.
Norton Rose Fulbright Canada LLP
On October 23, 2014, the Minister of National Revenue filed Notices of Application in the Federal Court against a number of generic drug manufacturers.
Gowling Lafleur Henderson LLP
Medical device manufacturers often have to defend against novel theories of liability put forward by plaintiff counsel.
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Canada LLP
The Government of Quebec tabled Bill 10, "An Act to modify the organization and governance of the health and social services network, in particular by abolishing the regional agencies."
Norton Rose Fulbright Canada LLP
On October 23, 2014, the Minister of National Revenue filed Notices of Application in the Federal Court against a number of generic drug manufacturers.
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Blake, Cassels & Graydon LLP
Bill C-17, An Act to Amend the Food and Drugs Act, received royal assent on November 6, 2014.
Norton Rose Fulbright Canada LLP
The Supreme Court of Canada announced yesterday that it has granted leave to appeal the decision of the Federal Court of Appeal in a proceeding commenced by Apotex.
Norton Rose Fulbright Canada LLP
The report of consultant, IBM Healthcare, contracted to study the system of pan-Canadian price negotiations, has been publicly released.
Norton Rose Fulbright Canada LLP
There have been a number of notable developments in recent weeks in respect of patent utility law in Canada.
Davis LLP
On November 6, 2014, Bill C-17 (the Protecting Canadians from Unsafe Drugs Act, aka Vanessa’s Law) (the "Act") received Royal Assent and came into law.
Gowling Lafleur Henderson LLP
Medical device manufacturers often have to defend against novel theories of liability put forward by plaintiff counsel.
Osler, Hoskin & Harcourt LLP
Health Canada has released its long-anticipated findings in the landmark Wind Turbine Noise and Health Study – the largest and most comprehensive study of its kind in the world.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners